Nebula Research & Development LLC Alkermes Plc. Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
A detailed history of Nebula Research & Development LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 8,924 shares of ALKS stock, worth $245,677. This represents 0.03% of its overall portfolio holdings.
Number of Shares
8,924
Previous 20,971
57.45%
Holding current value
$245,677
Previous $568 Million
62.11%
% of portfolio
0.03%
Previous 0.12%
Shares
2 transactions
Others Institutions Holding ALKS
# of Institutions
346Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$801 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$551 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$395 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$303 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$254 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.52B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...